StockData
Exagen Inc. logo

Exagen Inc. (XGN) income statement

XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/3010% above fair value
$3.90+0.14 (+3.72%)

Close on Nov 18, 2026Market cap $94.48MP/E –Yield –

Exagen Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
58.6%
Operating margin
-18.6%
Net margin
-26.6%
Return on equity, FY2025
-147.8%

Financial strength

Current ratio
3.18
Debt to equity
1.87
Debt to assets
44.0%
Cash to current liabilities
182.7%

Valuation

P/E ratio
–
Price to sales
1.33
Price to book
7.73
Dividend yield
–

See a number that looks wrong?